Novo Nordisk A S
Congress has disclosed 30 buys and 17 sells of NVO (Novo Nordisk A S) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying NVO and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Valerie Hoyle | 2024-10-29 | $103.79 | $40.00 | -61.5% | underwater |
| Michael McCaul | 2024-12-23 | $82.23 | $40.00 | -51.4% | underwater |
| Marjorie Taylor Greene | 2025-10-15 | $54.02 | $40.00 | -26.0% | underwater |
| Scott Franklin | 2026-08-26 | $47.19 | $40.00 | -15.2% | underwater |
| Alan Armstrong | 2026-03-30 | $34.84 | $40.00 | +14.8% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Legislation Related Legislation
Recent bills in this stock's sector (). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
47 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Kevin Hern | House | SELL | Self · Kevin Hern Traditional IRA | 2026-09-10 | 5 days | -3.4% | $1K–$15K 0.1% of NW |
97.7 | ↗ filing |
| Kevin Hern | House | SELL | Self · Kevin Hern Traditional IRA | 2026-08-31 | 15 days | -6.2% | $1K–$15K 0.1% of NW |
99.4 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Roth IRA | 2026-08-26 | 7 days | -0.9% | $1K–$15K 0.1% of NW |
31.8 | ↗ filing |
| Alan Armstrong | Senate | BUY | Self | 2026-03-30 | 113 days | +39.9% | $15K–$50K | 99.6 | ↗ eFD |
| Lisa McClain | House | SELL | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
60.1 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | -1.2% | $1K–$15K 0.1% of NW |
64.1 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | -1.2% | $1K–$15K 0.1% of NW |
66.9 | ↗ filing |
| Marjorie Taylor Greene | House | BUY | Self | 2025-10-15 | 1 days | -1.1% | $1K–$15K | 53.3 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab Brokerage Account 924 | 2025-09-11 | 20 days | +9.0% | $1K–$15K 0.1% of NW |
69.1 | ↗ filing |
| Marjorie Taylor Greene | House | BUY | Self | 2025-08-28 | 1 days | +0.6% | $1K–$15K | 93.5 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Traditional IRA | 2025-08-04 | 1 days | -3.3% | $15K–$50K 0.4% of NW |
48.5 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Roth IRA | 2025-08-04 | 1 days | -3.3% | $1K–$15K 0.1% of NW |
24.5 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Traditional IRA | 2025-08-04 | 1 days | -3.3% | $1K–$15K 0.1% of NW |
24.5 | ↗ filing |
| Scott Franklin | House | BUY | Spouse · Fidelity Roth IRA | 2025-08-04 | 1 days | -3.3% | $1K–$15K 0.1% of NW |
24.5 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-08-04 | 9 days | +4.3% | $1K–$15K 0.1% of NW |
82.7 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2025-07-30 | 6 days | -5.6% | $50K–$100K | 47.6 | ↗ filing |
| Lisa McClain | House | SELL | Spouse · Charles Schwab Brokerage Account 924 | 2025-07-10 | 34 days | -28.3% | $1K–$15K 0.1% of NW |
89.5 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-09 | 65 days | -32.5% | $1K–$15K 0.1% of NW |
97.4 | ↗ filing |
| Laurel Lee | House | SELL | Spouse | 2025-05-08 | 27 days | +11.1% | $1K–$15K 0.1% of NW |
97.5 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Roth IRA | 2025-03-27 | 11 days | -7.8% | $1K–$15K 0.1% of NW |
63.3 | ↗ filing |
| Scott Franklin | House | BUY | Self · Fidelity Traditional IRA | 2025-03-27 | 11 days | -7.8% | $15K–$50K 0.4% of NW |
82.1 | ↗ filing |
| Byron Donalds | House | SELL | Self · Moran Wealth IRA | 2025-03-20 | 18 days | -17.9% | $1K–$15K 0.3% of NW |
64.8 | ↗ filing |
| Byron Donalds | House | SELL | Spouse · Moran Wealth IRA | 2025-03-20 | 18 days | -17.9% | $1K–$15K 0.3% of NW |
64.8 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-12-23 | 13 days | -1.2% | $15K–$50K | 18.5 | ↗ filing |
| Michael McCaul | House | BUY OCR | Child | 2024-12-23 | 13 days | -1.2% | $15K–$50K | 18.5 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-10-31 | 5 days | -1.6% | $15K–$50K | 29.7 | ↗ filing |
| Michael McCaul | House | BUY OCR | Child | 2024-10-31 | 5 days | -1.6% | $15K–$50K | 29.7 | ↗ filing |
| Valerie Hoyle | House | BUY | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | -50.2% | $1K–$15K 0.8% of NW |
69.5 | ↗ filing |
| John James | House | SELL | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -2.7% | $1K–$15K <0.1% of NW |
89.3 | ↗ filing |
| Michael McCaul | House | SELL OCR | Spouse | 2024-08-26 | 10 days | -3.3% | $1K–$15K | 13.4 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-08-09 | 27 days | — | $15K–$50K | 19.1 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-05-29 | 7 days | — | $15K–$50K | 20.1 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-05-28 | 8 days | — | $15K–$50K | 25.4 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-05-06 | 30 days | — | $15K–$50K | 28.8 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-04-24 | 12 days | — | $50K–$100K | 53.5 | ↗ filing |
| Michael McCaul | House | BUY OCR | Child | 2024-04-24 | 12 days | — | $50K–$100K | 53.5 | ↗ filing |
| Michael McCaul | House | BUY OCR | Spouse | 2024-04-23 | 13 days | — | $100K–$250K | 96.7 | ↗ filing |
| Michael McCaul | House | BUY OCR | Child | 2024-04-23 | 13 days | — | $50K–$100K | 94.3 | ↗ filing |
| John James | House | BUY | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
98.8 | ↗ filing |
| Daniel Goldman | House | SELL | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-07-10 | 25 days | — | $250K–$500K 0.2% of NW |
97.6 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2021-09-16 | 27 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2020-11-05 | 53 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2019-05-28 | 21 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Katherine Clark | House | SELL | Spouse | 2017-01-05 | 137 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Katherine Clark | House | BUY | Spouse | 2016-10-11 | 197 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Robert Wittman | House | BUY | Self | 2015-09-15 | 3 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
FAQ Common questions
How much has Congress traded NVO?
30 disclosed buys and 17 sells of NVO (Novo Nordisk A S) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade NVO?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.